Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ZUCKERMANN, Andreas")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 45

  • Page / 2
Export

Selection :

  • and

Clinical experience with Certican® (everolimus) in maintenance heart transplant patients at the Medical University of ViennaZUCKERMANN, Andreas.The Journal of heart and lung transplantation. 2005, Vol 24, Num 4S, pp S206-S209, issn 1053-2498, SUPArticle

Immunosuppressive therapy in older cardiac transplant patientsZEJNAB ALIABADI, Arezu; ZUCKERMANN, Andreas Oliver; GRIMM, Michael et al.Drugs & aging. 2007, Vol 24, Num 11, pp 913-932, issn 1170-229X, 20 p.Article

From clinical trials to clinical practice : An overview of Certican® (everolimus) in heart transplantationVALANTINE, Hannah; ZUCKERMANN, Andreas.The Journal of heart and lung transplantation. 2005, Vol 24, Num 4S, pp S185-S190, issn 1053-2498, SUPArticle

Effects of Donor Pre-Treatment With Dopamine on Survival After Heart Transplantation: A Cohort Study of Heart Transplant Recipients Nested in a Randomized Controlled Multicenter TrialBENCK, Urs; HOEGER, Simone; BITTNER, Hartmuth B et al.Journal of the American College of Cardiology. 2011, Vol 58, Num 17, pp 1768-1777, issn 0735-1097, 10 p.Article

Complete revascularization in coronary artery bypass grafting with and without cardiopulmonary bypassCZERNY, Martin; BAUMER, Harald; KILO, Juliane et al.The Annals of thoracic surgery. 2001, Vol 71, Num 1, pp 165-169, issn 0003-4975Article

Impact of De Novo Everolimus-Based Immunosuppression on Incisional Complications in Heart TransplantationZUCKERMANN, Andreas; ARIZON, Jose M; DONG, Gaohong et al.Transplantation. 2011, Vol 92, Num 5, pp 594-600, issn 0041-1337, 7 p.Article

Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapyGEUSAU, Alexandra; DUNKLER, Daniela; MESSERITSCH, Eva et al.International journal of dermatology. 2008, Vol 47, Num 9, pp 918-925, issn 0011-9059, 8 p.Article

Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trialZUCKERMANN, Andreas; REICHENSPURNER, Hermann; BIRSAN, Tudor et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 125, Num 4, pp 891-900, issn 0022-5223, 10 p.Article

Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipientsKOCHER, Alfred A; BONAROS, Nikolaos; DUNKLER, Daniela et al.The Journal of heart and lung transplantation. 2003, Vol 22, Num 3, pp 250-257, issn 1053-2498, 8 p.Article

Response of Right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantationHÜLSMANN, Martin; STEFENELLI, Thomas; BERGER, Rudolf et al.The Journal of heart and lung transplantation. 2000, Vol 19, Num 10, pp 939-945, issn 1053-2498Article

Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathySALAMA, Mohamed; ANDRUKHOVA, Olena; ROEDLER, Susanne et al.Journal of thoracic and cardiovascular surgery (Print). 2011, Vol 142, Num 5, pp 1246-1253, issn 0022-5223, 8 p.Article

Donor myocardial apollon mRNA is associated with cardiac allograft rejectionAHARINEJAD, Seyedhossein; ANDRUKHOVA, Olena; GMEINER, Matthias et al.The Journal of heart and lung transplantation. 2010, Vol 29, Num 7, pp 777-785, issn 1053-2498, 9 p.Article

Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart TransplantationZUCKERMANN, Andreas; MANITO, Nicolas; VALANTINE, Hannah et al.The Journal of heart and lung transplantation. 2008, Vol 27, Num 2, pp 141-149, issn 1053-2498, 9 p.Article

Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantationTAGHAVI, Shahrokh; ZUCKERMANN, Andreas; ANKERSMIT, Jan et al.The Annals of thoracic surgery. 2004, Vol 78, Num 5, pp 1644-1649, issn 0003-4975, 6 p.Article

Survival benefit of the implantable cardioverter-defibrillator in patents on the waiting list for cardiac transplantationSANDNER, Sigrid E; WIESELTHALER, Georg; ZUCKERMANN, Andreas et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 12, pp I.171-I.176, issn 0009-7322, SUPArticle

Programmed Cell Death in Idiopathic Dilated Cardiomyopathy is Mediated by Suppression of the Apoptosis Inhibitor Apollon. DiscussionAHARINEJAD, Seyedhossein; ANDRUKHOVA, Olena; LUCAS, Trevor et al.The Annals of thoracic surgery. 2008, Vol 86, Num 1, pp 109-114, issn 0003-4975, 6 p.Article

Recommendations for the use of everolimus (certican) in heart transplantation : Results from the second german-austrian certican consensus conferenceROTHENBURGER, Markus; ZUCKERMANN, Andreas; BARA, Christoph et al.The Journal of heart and lung transplantation. 2007, Vol 26, Num 4, pp 305-311, issn 1053-2498, 7 p.Article

Ten-year follow-up of a prospective, randomized trial of BT563/ BB10 versus anti-thymocyte globulin as induction therapy after heart transplantationBONAROS, Nikolaos; DUNKLER, Daniela; KOCHER, Alfred et al.The Journal of heart and lung transplantation. 2006, Vol 25, Num 9, pp 1154-1163, issn 1053-2498, 10 p.Article

Heart transplantation provides long-term survival benefit in stable patients experiencing heart failure without reverse left ventricular remodelingMEYER, Brigitte; MOERT, Deddo; HUELSMANN, Martin et al.Transplantation. 2006, Vol 82, Num 11, pp 1463-1471, issn 0041-1337, 9 p.Article

Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipientsBONAROS, Nikolaos E; KOCHER, Alfred; DUNKLER, Daniela et al.Transplantation. 2004, Vol 77, Num 6, pp 890-897, issn 0041-1337, 8 p.Article

Sequential Big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantationSTRAMETZ-JURANEK, Jeanette; PACHER, Richard; KOS, Thomas et al.The Journal of heart and lung transplantation. 2003, Vol 22, Num 7, pp 731-737, issn 1053-2498, 7 p.Article

Long-term survival (> 10 years) of patients >60 years with induction therapy after cardiac transplantation. DiscussionZUCKERMANN, Andreas; DUNKLER, Daniela; DEVIATKO, Elena et al.European journal of cardio-thoracic surgery. 2003, Vol 24, Num 2, pp 283-291, issn 1010-7940, 9 p.Conference Paper

Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipientsWEIGEL, Guenter; GRIESMACHER, Andrea; KARIMI, Ali et al.The Journal of heart and lung transplantation. 2002, Vol 21, Num 10, pp 1074-1079, issn 1053-2498Article

Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipientsWEIGEL, Guenter; GRIESMACHER, Andrea; ZUCKERMANN, Andreas O et al.Clinical pharmacology and therapeutics. 2001, Vol 69, Num 3, pp 137-144, issn 0009-9236Article

Apollon/RNF41 Myocardial Messenger RNA Diagnoses Cardiac Allograft Apoptosis in RejectionAHARINEJAD, Seyedhossein; ANDRUKHOVA, Olena; GMEINER, Matthias et al.Transplantation. 2010, Vol 89, Num 2, pp 245-252, issn 0041-1337, 8 p.Article

  • Page / 2